Mycio Wealth Partners, LLC Abb Vie Inc. Transaction History

Mycio Wealth Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $257,677 - $390,671	-3,995 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $27,553 - $34,475	382 Added 10.57%	3,995 $354,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $7,368 - $8,859	-117 Reduced 3.14%	3,613 $274,000
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $245,061 - $313,245	3,730 New	3,730 $271,000
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $189,147 - $222,617	-2,452 Closed	0 $0
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $15,336 - $18,913	-197 Reduced 7.44%	2,452 $226,000
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $129,986 - $144,504	-1,462 Reduced 35.56%	2,649 $251,000
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $46,005 - $61,605	-500 Reduced 10.84%	4,111 $389,000
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $44,780 - $49,105	500 Added 12.16%	4,611 $446,000
Q3 2017 Oct 19, 2017	SELL	$69.85 - $89.22 $8,382 - $10,706	-120 Reduced 2.84%	4,111 $365,000
Q2 2017 Aug 10, 2017	SELL	N/A	-3,790 Reduced 47.25%	4,231 $307,000
Q2 2017 Aug 08, 2017	BUY	N/A	8,021	8,021 $523,000

3,697

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mycio Wealth Partners, LLC with notifications on news.